The DOI matches its Crossref record; 126 of the 128 references it cites were found in a registry or an index.
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Open accessAbstract
Models of liver fibrosis, which include cell culture models, explanted and biopsied human material, and experimental animal models, have demonstrated that liver fibrosis is a highly dynamic example of solid organ wound healing. Recent work in human and animal models has shown that liver fibrosis is potentially reversible and, in specific circumstances, demonstrates resolution with a restoration of near normal architecture. This Review highlights the manner in which studies of models of liver fibrosis have contributed to the paradigm of dynamic wound healing in this solid organ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fibrotic diseases it has been shown that the accumulation of ECM components can be driven primarily by inflammatory processes [59].”
From Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity (2008) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citationFusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Álvarez‐Dolado, M., Pardal, R., García‐Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J., & Álvarez-Buylla, A. (2003) · Nature · doi:10.1038/nature02069 · Cited by 1,617
Research works printed but not linked: 9
- 10.1172/JCI200524282 · DOI · Paper page
- Otto, 1980, Adv. Exp. Med. Biol., 132, 509
- Constandinou, 2005, Methods Mol. Med., 117, 237
- Montfort, 1978, Am. J. Pathol., 92, 411
- Jeong, 2002, Anticancer Res., 22, 869
- Okazaki, 1998, Lab. Invest., 78, 1431
- 10.1172/JCI200320530 · DOI
- 10.1053/gast.1996.v110.pm8608892 · DOI · Paper page
- 10.1074/jbc.275.4.2247 · DOI
Cited by
Sorted by citations
Items 401–500 of 865
Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics
Singh, S., Sharma, N., Shukla, S., Behl, T., Gupta, S., Anwer, M. K., Vargas-De-La-Cruz, C. B., BUNGAU, S. G., & Brisc, M. C. (2023) · Molecules · doi:10.3390/molecules28062811 · Cited by 34
Therapeutic potential of microneedles based delivery systems for the management of atopic dermatitis
Shukla, S., Mamale, K., Arya, R. K. K., Kaundal, R. K., & Shukla, R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104493 · Cited by 30
Xu, X., Guo, Y., Luo, X., Shen, Z., Sun, Z., Shen, B., Zhou, C. L., Wang, J., Lu, J., Zhang, Q., et al. (2023) · Liver International · doi:10.1111/liv.15715 · Cited by 31
Comparison of TGF-β, PDGF, and CTGF in hepatic fibrosis models using DMN, CCl4, and TAA
Park, H. J., Kim, H.-G., Wang, J., Choi, M., Han, J., Lee, J., & Son, C. (2015) · Drug and Chemical Toxicology · doi:10.3109/01480545.2015.1052143 · Cited by 30
Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection
Qiu, W., Guo, K., Yi, L., Gong, Y., Huang, L., & Zhong, W. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1641 · Cited by 30
Canine visceral leishmaniasis as a systemic fibrotic disease
Silva, L. C., de Castro, R. S., Figueiredo, M. M., Michalick, M. S. M., Tafuri, W. L., & Tafuri, W. L. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12010 · Cited by 29
Sakai, K., Jawaid, S., Sasaki, T., Bou–Gharios, G., & Sakai, T. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.06.009 · Cited by 29
Description of Prototype Modes-of-Action Related to Repeated Dose Toxicity
Landesmann, B., Paraskevi, G. M., Sharon, M., & Maurice, W. (2012) · Joint Research Centre (European Commission) · doi:10.2788/71112 · Cited by 29
Xu, X., Du, Y. Z., Liu, X., Ren, Y., Dong, Y., Xu, H., Shi, J., Jiang, D., Xu, X. W., Li, L., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00610-0 · Cited by 31
Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice
Momen‐Heravi, F., Catalano, D. E., Talis, A., Szabó, G., & Bala, S. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.05.007 · Cited by 29
A narrative review of liver regeneration—from models to molecular basis
Huang, W., Han, N., Du, L., Wang, M., Chen, L., & Tang, H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-5234 · Cited by 29
Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.
Papachrysos, N., Hytiroglou, P., Papalavrentios, L., Sinakos, E., Kouvelis, I., & Akriviadis, E. A. (2015) · PubMed Central · Cited by 28
Wang, D., Zhang, C., Liu, H., Cui, Y., Li, X., Zhang, Z., & Zhang, Y. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s101366 · Cited by 29
A retrospective study of oral prednisolone treatment in canine chronic hepatitis
Favier, R. P., Poldervaart, J. H., van den Ingh, T. S. G. A. M., Penning, L. C., & Rothuizen, J. J. (2013) · Veterinary Quarterly · doi:10.1080/01652176.2013.826881 · Cited by 28
cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation.
Franko, A., Kovářová, M., Feil, S., Feil, R., Wagner, R., Heni, M., Königsrainer, A., Ruoß, M., Nussler, A., Weigert, C., et al. (2018) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2018.09.001 · Cited by 24
Cardoso, C. C., Matiollo, C., Pereira, C. H. J., Fonseca, J. S., Alves, H. E. L., da Silva, O. M., Menegassi, V. D. S., dos Santos, C. R., de Moraes, A. C. R., Schiavon, L. D. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85148-y · Cited by 28
Sahyon, H. A. E., El‐Shafai, N. M., El‐Mehasseb, I. M., Althobaiti, F., Aldhahrani, A., & Elnajjar, N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123804 · Cited by 29
Huang, K., Huang, Y.-C., Tai, K., Chen, B.-H., Lee, P., & Hwang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.160 · Cited by 28
Tang, Y., Hu, C., & Liu, Y. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.03.067 · Cited by 28
The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
Triposkiadis, F. K., Starling, R. C., Boudoulas, H. K., Giamouzis, G., & Butler, J. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9291-x · Cited by 27
Parajuli, D. R., Zhao, Y., Jin, H., Chi, J. H., Li, S. Y., Kim, Y., Sohn, D. H., & Lee, S. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0425-2 · Cited by 28
Lu, K., Weng, C., Chen, W., & Sheen, L. (2016) · Journal of Ginseng Research · doi:10.1016/j.jgr.2016.06.002 · Cited by 28
Wang, Z., Yuan, M., Yao, L., Xiong, Z., Dai, K., Liu, P., Chen, P., Sun, M., Shu, K., Xia, Y., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03291-4 · Cited by 27
Mattos, A., de Jager-Krikken, A., de Haan, M., Beljaars, L., & Poelstra, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.041 · Cited by 27
Pérez‐Carreón, J. I., Martínez-Pérez, L., Loredo, M. L., Yañez-Maldonado, L., Velasco-Loyden, G., Vidrio, S., Ramírez-Salcedo, J., Hernández‐Luis, F., Velázquez‐Martínez, I., Suárez‐Cuenca, J. A., et al. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.005 · Cited by 27
Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis
Varlamova, E. G., Goltyaev, M. V., Rogachev, V. V., Gudkov, S. V., Karaduleva, E. V., & Turovsky, E. A. (2023) · Cells · doi:10.3390/cells12232723 · Cited by 29
Hassan, N. H., Kamel, G. M., Fayed, H. M., Korany, R. M. S., & Ramadan, A. (2025) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2025.2496661 · Cited by 26
Lamontagne, A., Long, R. E., Comunale, M. A., Hafner, J., Rodemich-Betesh, L., Wang, M., Marrero, J. A., Bisceglie, A. M. D., Block, T. M., & Mehta, A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064992 · Cited by 26
Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies
Cannito, S., Milani, C., Cappon, A., Parola, M., Strazzabosco, M., & Cadamuro, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123875 · Cited by 26
MANF regulates splenic macrophage differentiation in mice
Hou, C., Wang, D., Li, X., He, Y., Wei, C., Jiang, R., Liu, J., Feng, L., & Shen, Y. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.06.007 · Cited by 26
Meirelles, L. D. S., Marson, R. F., Solari, M. I. G., & Nardi, N. B. (2020) · Cells · doi:10.3390/cells9010188 · Cited by 26
Mukherjee, P., Miyazawa, A., Fukuda, S., Yamashita, T., Lukmanto, D., Okada, K., El-Sadek, I. A., Zhu, L., Makita, S., Oshika, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98909-6 · Cited by 26
Mouse Models of Liver Parenchyma Injuries and Regeneration
Du, Y., Zhang, W., Qiu, H., Xiao, C., Shi, J., Reid, L. M., & He, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.903740 · Cited by 28
Targeting Hepatic Stellate Cell Death to Reverse Hepatic Fibrosis
Zhang, X., Zeng, Y., Zhao, L., Xu, Q., Miao, D., & Yu, F. (2023) · Current Drug Targets · doi:10.2174/1389450124666230330135834 · Cited by 26
Sebastiani, G., Gkouvatsos, K., Maffettone, C., Busatto, G., Guido, M., & Pantopoulos, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025138 · Cited by 26
Ruehl, M., Erben, U., Kim, K., Freise, C., Dagdelen, T., Eisele, S., Trowitzsch‐Kienast, W., Zeitz, M., Jia, J., Stickel, F., et al. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.06.003 · Cited by 26
Attia, H., Al-Rasheed, N. M., Mohamad, R. A., Al‐Rasheed, N. M., & Alamin, M. A. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1388-2 · Cited by 26
Al‐Fayoumi, S., Hashiguchi, T., Shirakata, Y., Mascarenhas, J. O., & Singer, J. W. (2018) · Journal of Experimental Pharmacology · doi:10.2147/jep.s150729 · Cited by 27
Fibrosis in tissue engineering and regenerative medicine: treat or trigger?
Fernández‐Colino, A., Iop, L., Ferreira, M. S. V., & Mela, P. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.07.007 · Cited by 28
Šelc, M., Macova, R., & Bábelová, A. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s483140 · Cited by 26
Effect of Rho A on transforming growth factor β1‐induced rat hepatic stellate cell migration
Li, L., Wang, J., Yang, C., & Jiang, W. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02809.x · Cited by 25
Hussain, A. R., Gul, M. A., & Khalid, M. U. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2019-000316 · Cited by 25
Heinrichs, D., Brandt, E. F., Fischer, P., Köhncke, J., Wirtz, T. H., Güldiken, N., Djudjaj, S., Boor, P., Kroy, D. C., Weiskirchen, R., et al. (2021) · Cells · doi:10.3390/cells10020252 · Cited by 25
Li, Z., Wang, Z., Dong, F., Shi, W., Dai, W., Zhao, J., Li, Q., Fang, Z.-E., Ren, L., Liu, T., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.745561 · Cited by 24
Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
Li, L., & Zhu, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1071844 · Cited by 26
Dong, S., & Su, S.-B. (2014) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(14)60022-4 · Cited by 25
Twu, Y., Lee, T., Lin, Y., Hsu, S., Wang, Y.-H., Liao, C.-Y., Wang, C.-K., Liang, Y., & Liao, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071122 · Cited by 25
Huang, X., Cai, H., Ammar, R., Zhang, Y., Wang, Y., Ravi, K., Thompson, J. R., & Járai, G. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00281.2018 · Cited by 24
El-Baz, F. K., Salama, A., Ali, S. I., & Elgohary, R. (2021) · BioMed Research International · doi:10.1155/2021/6631415 · Cited by 25
Artificial Intelligence in Liver Diseases: Recent Advances
Lu, F., Meng, Y., Song, X., Li, X., Liu, Z., Gu, C., Zheng, X., Yi, J., Cai, W., Pinyopornpanish, K., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02781-5 · Cited by 28
Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy
Terán-Hinojosa, E., Sobral, H., Sanchez-Perez, C. A., Pérez-García, A., Alemán-García, N., & Hernández-Ruiz, J. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.003816 · Cited by 24
Carbon Tetrachloride-Induced Hepatotoxicity*
Fujimoto, J., & Iimuro, Y. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01018-6 · Cited by 24
Kong, Y., Wang, H., Wang, S., & Tang, N. (2014) · Inflammation · doi:10.1007/s10753-014-9877-2 · Cited by 24
Role of cellular senescence in hepatic wound healing and carcinogenesis
Ramakrishna, G., Anwar, T., Angara, R. K., Chatterjee, N., Kiran, S., & Singh, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.08.002 · Cited by 23
Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis
Schaffert, C. S., Duryee, M. J., Bennett, R. G., DeVeney, A. L., Tuma, D. J., Olinga, P., Easterling, K. C., Thiele, G. M., & Klassen, L. W. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00287.2009 · Cited by 24
Mechanocompatible Polymer‐Extracellular‐Matrix Composites for Vascular Tissue Engineering
Jiang, B., Suen, R. M., Wang, J.-J., Zhang, Z. J., Wertheim, J. A., & Ameer, G. A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201501003 · Cited by 25
Zhang, D., Guo, Z., Zhang, P., Li, Y., Su, X., You, L., Gao, M., Liu, C., Wu, H., & Zhang, X. (2016) · Scientific Reports · doi:10.1038/srep25377 · Cited by 24
AICD: an integrated anti-inflammatory compounds database for drug discovery
Wang, K., Xiao, J., Liu, X., Jiang, Z., Zhan, Y., Yin, T., He, L., Zhang, F., Xing, S., Chen, B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44227-x · Cited by 23
Targeted TFO delivery to hepatic stellate cells
Yang, N., Singh, S. P., & Mahato, R. I. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.037 · Cited by 23
Lee, S. J., Kang, J. H., Choi, S. Y., Suk, K. T., Kim, D. J., & Kwon, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055979 · Cited by 23
Klironomos, S., Notas, G., Sfakianaki, O., Kiagiadaki, F., Xidakis, C., & Kouroumalis, E. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.11.002 · Cited by 23
Takemura, T., Yoshida, Y., Kiso, S., Saji, Y., Ezaki, H., Hamano, M., Kizu, T., Egawa, M., Chatani, N., Furuta, K., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01074.x · Cited by 23
Bornstein, R., Macías, M. I., de la Torre, P., Grande, J., & Flores, A. I. (2012) · Cytotherapy · doi:10.3109/14653249.2012.706706 · Cited by 23
Biomarkers for liver fibrosis: Advances, advantages and disadvantages
Cequera, A., & Méndez, M. C. G. D. L. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.07.001 · Cited by 23
Khatami, M. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0193-6 · Cited by 23
Sayed, N., Khurana, A., Saifi, M. A., Singh, M. S., & Godugu, C. (2019) · BioFactors · doi:10.1002/biof.1546 · Cited by 24
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
Fumoto, S., Yamamoto, T., Okami, K., Maemura, Y., Terada, C., Yamayoshi, A., & Nishida, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020159 · Cited by 23
Ohayon, O., Mawasi, N., Pevzner, A., Tryvitz, A., Gildor, T., Pines, M., Rojkind, M., Paizi, M., & Spira, G. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.30 · Cited by 22
Lucendo‐Villarin, B., Cameron, K., Szkolnicka, D., Rashidi, H., Bates, N., Kimber, S. J., Flint, O. P., Forbes, S. J., Iredale, J. P., Bradley, M., et al. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500391 · Cited by 22
Self-citationGuo, Y., Zhang, Y. L., Zhang, Q., Guo, X., Zhang, H., Zheng, G., & Liu, L. (2014) · Hepatology International · doi:10.1007/s12072-014-9578-9 · Cited by 22
Sungkar, T., Putra, A. B., Lindarto, D., & Sembiring, R. J. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.177-182 · Cited by 22
Mohamed, A. E., Mahmoud, A. M., Mohamed, W. R., & Mohamed, T. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120877 · Cited by 22
Immunological Orchestration of Liver Fibrosis
Tanaka, H., Leung, P. S. C., Kenny, T. P., Gershwin, M. E., & Bowlus, C. L. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8323-1 · Cited by 21
Epimorphin Alters the Inhibitory Effects of SOX9 on Mmp13 in Activated Hepatic Stellate Cells
Pritchett, J. P., Athwal, V. S., Harvey, E., Martin, K., Llewellyn, J., Ireland, P., Nicolaides, A., Humphries, M. J., Bobola, N., Hanley, N. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100091 · Cited by 22
Parajuli, D. R., Park, E., Che, X., Jiang, W., Kim, Y., Sohn, D. S., & Lee, S. (2013) · Molecules · doi:10.3390/molecules18022122 · Cited by 22
Lu, N., Liu, Y., Tang, A., Chen, L., Miao, D., & Yuan, X. (2015) · BioMed Research International · doi:10.1155/2015/794862 · Cited by 21
Ma, J., Zhang, L., Zhang, X., Zhang, L., Zhang, H., Zhu, Y., Huang, X., Zhang, T., Tang, X., Wang, Y., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado5266 · Cited by 22
Yang, X. F., Han, Z.-P., Zhang, S., Zhu, P.-X., Hao, C., Fan, T.-T., Yang, H. J., Li, L., Shi, Y.-F., & Wei, L.-X. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.257 · Cited by 21
Wang, Y., Terrell, A. M., Riggio, B. A., Anand, D., Lachke, S. A., & Duncan, M. K. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21721 · Cited by 21
Utility of glutamine synthetase immunohistochemistry in identifying features of regressed cirrhosis
Hadi, R., Shin, K. S., Reder, N. P., Alpert, L., Koch, L., Choi, W., Swanson, P. E., Hart, J. A. L., & Westerhoff, M. A. (2019) · Modern Pathology · doi:10.1038/s41379-019-0346-1 · Cited by 21
Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
Pu, S., Li, Y., Liu, Q., Zhang, X., Chen, L., Li, R., Zhang, J., Wu, T., Tang, Q., Yang, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.628583 · Cited by 21
Kim, J., Lee, S. H., Jeong, S., Kim, H., Ahn, K. S., Cho, J. Y., Yoon, Y., & Han, H. (2010) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.222.319 · Cited by 21
BML-11, A Lipoxin Receptor Agonist, Protected Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats
Zhou, X., Yu, Z., Yan, D., Wang, H., Huang, Y., Sha, J., Xu, F., Cai, Z., & Min, W. (2013) · Inflammation · doi:10.1007/s10753-013-9643-x · Cited by 21
Zhang, J., WANG, M., ZHANG, Z., Luo, Z., Liu, F., & Liu, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3048 · Cited by 21
Systemic inhibition of BMP1-3 decreases progression of CCl4-induced liver fibrosis in rats
Grgurević, L., Erjavec, I., Grgurević, I., Dumić-Čule, I., Brkljačić, J. M., Verbanac, D., Matijašić, M., Paljetak, H. Č., Novak, R., Plečko, M., et al. (2017) · Growth Factors · doi:10.1080/08977194.2018.1428966 · Cited by 21
Fraczek, J., van Grunsven, L. A., Vinken, M., Sarah, S., Deleu, S., Vanderkerken, K., Vanhaecke, T., & Rogiers, V. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00831.x · Cited by 21
Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis
Melton, A. C., Soon, R. K., Park, J. G., Martinez, L., deHart, G. W., & Yee, H. F. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00134.2007 · Cited by 21
Can Vitamin D Levels Alter the Effectiveness of Short-Term Facelift Interventions?
Trifan, D. F., Tirla, A. G., Moldovan, A. F., Moş, C., Bodog, F., Maghiar, T. T., Manole, F., & Ghitea, T. C. (2023) · Healthcare · doi:10.3390/healthcare11101490 · Cited by 20
de Carvalho, S. N., Helal‐Neto, E., de Andrade, D. C., Cortez, E. A. C., Thole, A. A., Barja‐Fidalgo, C., & de Carvalho, L. (2013) · Cells Tissues Organs · doi:10.1159/000353215 · Cited by 20
Ou, X., Mao, S., Cao, J., Ma, Y., Ma, G., Cheng, A., Wang, M., Zhu, D., Chen, S., Jia, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19003 · Cited by 20
Multiphase modeling of tumor growth with matrix remodeling and fibrosis
Tosin, A., & Preziosi, L. (2010) · Mathematical and Computer Modelling · doi:10.1016/j.mcm.2010.01.015 · Cited by 20
Bei, R., Masuelli, L., Palumbo, C., Tresoldi, I., Scardino, A., & Modesti, A. (2008) · International Reviews of Immunology · doi:10.1080/08830180801939280 · Cited by 20
Hintermann, E., Bayer, M., Ehser, J., Aurrand‐Lions, M., Pfeilschifter, J. M., Imhof, B. A., & Christen, U. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2016.1178448 · Cited by 20
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
Singh, H. D., Otano, I., Rombouts, K., Singh, K. P., Peppa, D., Gill, U. S., Böttcher, K., Kennedy, P. T. F., Oben, J. A., Pinzani, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05845-5 · Cited by 20
Rare earth cerium oxide nanoparticles attenuated liver fibrosis in bile duct ligation mice model
Godugu, C., Khurana, A., & Saifi, M. A. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127102 · Cited by 19
Moderately High Folic Acid Supplementation Exacerbates Experimentally Induced Liver Fibrosis in Rats
Marsillach, J., Ferré, N., Camps, J., Riu, F., Rull, A., & Joven, J. (2008) · Experimental Biology and Medicine · doi:10.3181/0703-rm-59 · Cited by 19
Kim, S. E., Park, J. W., Kim, M., Jang, B., Jeon, Y., Kim, H., Ishigami, A., Kim, H. S., Suk, K. T., Kim, D. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201744 · Cited by 19
Sharkawy, R. E., Bayoumi, A., Metwally, M., Mangia, A., Berg, T., Romero‐Gómez, M., Abate, M. L., Irving, W. L., Sheridan, D. A., Dore, G. J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-35736-2 · Cited by 19
Biomarcadores para fibrosis hepática, avances, ventajas y desventajas
Cequera, A., & Méndez, M. C. G. D. L. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.05.003 · Cited by 19
Choi, J., Kim, J. K., Yang, Y. J., Kim, Y., Kim, P., Park, S. G., Cho, E. Y., Lee, D. H., & Choi, J. W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.002 · Cited by 19
Metadata
- Authors
- Iredale, J. P.
- Affiliations
- Centre for Inflammation Research (GB)
- Corresponding author
- Iredale, John P.
- ORCID
- Iredale, John P.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 539-548
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1804370
- OpenAlex
- W2120335459
- Cited by
- 866
- References
- 128
- Citations by year
- 2026: 19 · 2025: 40 · 2024: 45 · 2023: 39 · 2022: 32 · 2021: 39 · 2020: 34 · 2019: 36 · 2018: 39 · 2017: 36 · 2016: 51 · 2015: 63 · 2014: 61 · 2013: 57 · 2012: 55
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Children's Liver Disease Foundation
- Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver fibrosis, wound healing, inflammation, tissue repair, animal models, cell culture model, liver regeneration
- MeSH terms
- Animals, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Humans, Inflammation, Liver Cirrhosis, Liver Cirrhosis, Experimental, Liver Regeneration, Models, Biological, Wound Healing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review